Activities

Click on the tabs to view more information on our activities.

Joint webinar ECCR – Turkish Society of Pharmacology

Covid-19 and the Cardiovascular System: From Basic Mechanisms to Clinical Perspectives – Jan 27^th, 2021 (3-5 pm CET)

Cardiovascular disease as a risk factor and complication of COVID-19 – Rhian Touyz, Glasgow, UK

Covid-19, an endothelial disease – Thomas Lüscher, Zürich, Switzerland

Round Table -New Evidences and Possible Treatment Options Targeting Cardiovascular System

• Covid 19 and vascular aging –  Rosa M Bruno, Paris, France
• Covid-19 and ACE2- RAAS Inhibition – Matthias Barton, Zürich, Switzerland
• Covid 19 and eicosanoids – omega-3 derived pro-resolving lipid mediators – Gokce Topal, Istanbul, Turkey

Experimental Biology 2020 Symposium of the American Physiological Society

The Protective Arm of the Renin-Angiotensin System – April 13^th, 2021 (2.00 -3.30 pm)

Chairs: Rhian Touyz, Glasgow and Thomas Unger, Maastricht

Speakers:
• The meaning of Mas – Michael Bader, Max-Delbrück-Center for Molecular Medicine (MDC)
• The many aspects of cross-talk between the AT2-receptor and Mas – Ulrike Muscha
Steckelings, University of Southern Denmark
• The protective ACE2/Ang 1-7/Mas axis in stroke – Colin Sumners College of Medicine,
University of Florida Gainesville
• Novel therapeutic approaches upregulating the ACE2/angiotensin-(1-7)/Mas axis –
Ludovit Paulis, Comenius University, Bratislava, Slovakia
• AT2 agonists as treatment for vascular damage associated to obesity – Marta Gil-Ortega, Universidad San Pablo CEU, Madrid